Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital
Go back to Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 9.83 -0.69 (6.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.52 | 52 Week High | $82.81 | |||
| Open | $10.51 | 52 Week Low | $19.74 | |||
| Day High | $10.51 | P/E | N/A | |||
| Day Low | $9.81 | EPS | $-2.16 | |||
| Volume | 406,600 | |||||



